Magnus J. C. Sjögren
Institute of Clinical Neuroscience
Göteborg University
Sweden
Name/email consistency: high
- Treatment with simvastatin in patients with Alzheimer's disease lowers both alpha- and beta-cleaved amyloid precursor protein. Sjögren, M., Gustafsson, K., Syversen, S., Olsson, A., Edman, A., Davidsson, P., Wallin, A., Blennow, K. Dement. Geriatr. Cogn. Disord (2003)
- Advances in the detection of Alzheimer's disease-use of cerebrospinal fluid biomarkers. Sjögren, M., Andreasen, N., Blennow, K. Clin. Chim. Acta (2003)
- Biological correlates of clinical subgroups of Alzheimer's disease. Sjögren, M., Wikkelsö, C., Ostling, S., Wallin, A., Blennow, K. Dement. Geriatr. Cogn. Disord (2002)
- Cognition-enhancing effect of vagus nerve stimulation in patients with Alzheimer's disease: a pilot study. Sjögren, M.J., Hellström, P.T., Jonsson, M.A., Runnerstam, M., Silander, H.C., Ben-Menachem, E. J. Clin. Psychiatry (2002)
- Both total and phosphorylated tau are increased in Alzheimer's disease. Sjögren, M., Davidsson, P., Tullberg, M., Minthon, L., Wallin, A., Wikkelso, C., Granérus, A.K., Vanderstichele, H., Vanmechelen, E., Blennow, K. J. Neurol. Neurosurg. Psychiatr. (2001)
- EDRF transcripts and diagnosis of variant Creutzfeldt-Jakob disease. Sjögren, M. Lancet (2001)
- Tacrine and rate of progression in Alzheimer's disease--relation to ApoE allele genotype. Sjögren, M., Hesse, C., Basun, H., Köl, G., Thostrup, H., Kilander, L., Marcusson, J., Edman, A., Wallin, A., Karlsson, I., Troell, M., Wachtmaister, G., Ekdahl, A., Olofsson, H., Sandström, A., Andreasen, N., Minthon, L., Blennow, K. J. Neural. Transm (2001)
- Tau and Abeta42 in cerebrospinal fluid from healthy adults 21-93 years of age: establishment of reference values. Sjögren, M., Vanderstichele, H., Agren, H., Zachrisson, O., Edsbagge, M., Wikkelsø, C., Skoog, I., Wallin, A., Wahlund, L.O., Marcusson, J., Nägga, K., Andreasen, N., Davidsson, P., Vanmechelen, E., Blennow, K. Clin. Chem. (2001)
- Low cerebrospinal fluid beta-amyloid 42 in patients with acute bacterial meningitis and normalization after treatment. Sjögren, M., Gisslén, M., Vanmechelen, E., Blennow, K. Neurosci. Lett. (2001)
- Neurofilament protein in cerebrospinal fluid: a marker of white matter changes. Sjögren, M., Blomberg, M., Jonsson, M., Wahlund, L.O., Edman, A., Lind, K., Rosengren, L., Blennow, K., Wallin, A. J. Neurosci. Res. (2001)
- Cytoskeleton proteins in CSF distinguish frontotemporal dementia from AD. Sjögren, M., Rosengren, L., Minthon, L., Davidsson, P., Blennow, K., Wallin, A. Neurology (2000)
- Frontotemporal dementia can be distinguished from Alzheimer's disease and subcortical white matter dementia by an anterior-to-posterior rCBF-SPET ratio. Sjögren, M., Gustafson, L., Wikkelsö, C., Wallin, A. Dement. Geriatr. Cogn. Disord (2000)
- CSF levels of tau, beta-amyloid(1-42) and GAP-43 in frontotemporal dementia, other types of dementia and normal aging. Sjögren, M., Minthon, L., Davidsson, P., Granérus A-K, , Clarberg, A., Vanderstichele, H., Vanmechelen, E., Wallin, A., Blennow, K. J. Neural. Transm (2000)
